UBS cuts Docusign price target to $85, keeps neutral rating

Published 17/04/2025, 16:04
UBS cuts Docusign price target to $85, keeps neutral rating

On Thursday, UBS analysts, led by Karl Keirstead, adjusted the price target for Docusign Inc. (NASDAQ: DOCU) stock, lowering it to $85 from the previous $90, while maintaining a Neutral rating on the company. The revision followed the attendance of UBS analysts at DocuSign’s annual Momentum user conference and analyst session held in New York.

At the conference, DocuSign (NASDAQ:DOCU) unveiled its first AI agent and introduced new additions to its Identity Access Management (IAM) platform. The products sparked significant customer interest, particularly in the AI and IAM capabilities. The company’s strong financial health score of 3.12 on InvestingPro and impressive 79.25% gross profit margins suggest solid operational execution. However, several customers expressed concerns about increasing budget constraints influenced by macroeconomic factors and tariffs.

Keirstead noted that despite the absence of new financial or other disclosures at the investor session, the adjustments in price target reflect the current market conditions. He emphasized that with Docusign’s stock trading at 14 times the calendar year 2026 enterprise value to free cash flow (EV/FCF), the firm is reiterating its Neutral stance on the stock.

The UBS team’s presence at the conference provided an opportunity to gauge customer reactions firsthand, which played a part in their assessment of the company’s valuation and outlook. As of now, the revised price target suggests a more cautious view of DocuSign’s near-term financial performance in light of the noted economic pressures.

In other recent news, Docusign Inc. reported notable developments in its financial performance and received various analyst ratings. The company showcased a 9% growth in subscription revenue in its fourth-quarter earnings, surpassing expectations, and marked a 9% billings growth in the third quarter. Despite these positive results, UBS revised its price target for Docusign to $90, maintaining a Neutral stance due to conservative revenue guidance for fiscal year 2026. William Blair also maintained a Market Perform rating, noting strong adoption of Docusign’s Identity Authentication Management (IAM) platform, which is expected to drive future growth. Wells Fargo (NYSE:WFC) reiterated an Underweight rating with a $73 price target, citing challenges in accelerating growth amid foreign exchange headwinds and changes in compensation structures. Evercore ISI initiated coverage with an In Line rating and a $100 price target, highlighting Docusign’s solid performance in fiscal year 2025 and strategic growth opportunities in IAM. JMP Securities maintained a Market Outperform rating with a $124 target, confident in Docusign’s market leadership and growth potential. These recent developments reflect varied analyst perspectives, focusing on Docusign’s growth strategy and financial outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.